ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
67,005.07
-0.11%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Dimension Therapeutics, Inc. (DMTX)

  7. Dimension Therapeutics, Inc. (DMTX) Noticias

DMTX

DIMENSION THERAPEUTICS, INC. (DMTX)

Dimension Therapeutics, Inc.
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:DMTX
FechaHoraFuenteTítuloSímboloCompañía
17/11/201715:07Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:DMTXDimension Therapeutics, Inc.
14/11/201705:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:DMTXDimension Therapeutics, Inc.
09/11/201716:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DMTXDimension Therapeutics, Inc.
07/11/201710:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DMTXDimension Therapeutics, Inc.
07/11/201709:24Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:DMTXDimension Therapeutics, Inc.
07/11/201708:23Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:DMTXDimension Therapeutics, Inc.
07/11/201708:17Edgar (US Regulatory)(25-NSE)NASDAQ:DMTXDimension Therapeutics, Inc.
07/11/201708:15Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:DMTXDimension Therapeutics, Inc.
07/11/201707:57Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:DMTXDimension Therapeutics, Inc.
07/11/201707:43GlobeNewswire Inc.Ultragenyx Completes Tender Offer and Acquisition of Dimension TherapeuticsNASDAQ:DMTXDimension Therapeutics, Inc.
06/11/201715:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:DMTXDimension Therapeutics, Inc.
26/10/201707:30GlobeNewswire Inc.Ultragenyx and Dimension Announce Expiration of Hart-Scott-Rodino Waiting Period for Ultragenyx’s Acquisition of DimensionNASDAQ:DMTXDimension Therapeutics, Inc.
13/10/201710:18PR Newswire (US)WEISSLAW LLP: Dimension Therapeutics, Inc. Acquisition May Not Be in the Best Interests of DMTX ShareholdersNASDAQ:DMTXDimension Therapeutics, Inc.
10/10/201707:45Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:DMTXDimension Therapeutics, Inc.
10/10/201707:34Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:DMTXDimension Therapeutics, Inc.
05/10/201714:48PR Newswire (US)Harwood Feffer LLP Announces Investigation of Dimension Therapeutics, Inc.NASDAQ:DMTXDimension Therapeutics, Inc.
03/10/201715:19Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:DMTXDimension Therapeutics, Inc.
03/10/201715:05Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:DMTXDimension Therapeutics, Inc.
03/10/201709:00PR Newswire (US)Dimension (DMTX) Alert: Johnson Fistel Investigates Proposed Sale of Dimension Therapeutics, Inc.; Are Shareholders Getting a...NASDAQ:DMTXDimension Therapeutics, Inc.
03/10/201707:50Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:DMTXDimension Therapeutics, Inc.
03/10/201707:30GlobeNewswire Inc.Ultragenyx to Acquire Dimension TherapeuticsNASDAQ:DMTXDimension Therapeutics, Inc.
02/10/201708:22GlobeNewswire Inc.Ultragenyx Comments on Dimension Therapeutics’ Announcement that Ultragenyx’s Offer is a “Superior Proposal” NASDAQ:DMTXDimension Therapeutics, Inc.
02/10/201708:16Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:DMTXDimension Therapeutics, Inc.
02/10/201707:30GlobeNewswire Inc.REGENXBIO Responds to Notification of a Superior Proposal Under Its Merger Agreement With Dimension TherapeuticsNASDAQ:DMTXDimension Therapeutics, Inc.
19/09/201707:00GlobeNewswire Inc.Dimension Board of Directors Determines Proposal from Ultragenyx Pharmaceutical Inc. Could Reasonably Be Expected to Lead to ...NASDAQ:DMTXDimension Therapeutics, Inc.
18/09/201714:10GlobeNewswire Inc.Dimension Confirms Receipt of Unsolicited Proposal from UltragenyxNASDAQ:DMTXDimension Therapeutics, Inc.
18/09/201707:35GlobeNewswire Inc.Ultragenyx Proposes to Acquire Dimension Therapeutics for $5.50 Per Share in CashNASDAQ:DMTXDimension Therapeutics, Inc.
05/09/201705:00PR Newswire (US)OncoSec Appoints Industry Veteran Annalisa Jenkins MBBS, FRCP to Board of DirectorsNASDAQ:DMTXDimension Therapeutics, Inc.
31/08/201717:23PR Newswire (US)SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Dimension Therapeutics, Inc. - DMTXNASDAQ:DMTXDimension Therapeutics, Inc.
31/08/201707:00GlobeNewswire Inc.Dimension Therapeutics Commences Patient Dosing in Global, Multi-Center Phase 1/2 Clinical Trial of DTX301 in Ornithine Trans...NASDAQ:DMTXDimension Therapeutics, Inc.
 Showing the most relevant articles for your search:NASDAQ:DMTX

Su Consulta Reciente

UNSW
PUNDIXETH
Pundi X Token
ASX
SPFKOK
BIT
UB514R
Unicredit Bank
EU
HYSG
Hybrid Software
EU
Y439S
Y439S
NASDAQ
ABAOWXX
Hsbc Usa Inc Autocallabl...
AMEX
AVLC
Avantis US Large Cap Equ...
LSE
IUSA
Ishr S&p 500-i
NASDAQ
MOVE
Movano
LSE
XSOP
Wt Em X-soe Gbp
NASDAQ
LNUX
VA Software
USOTC
CBDS
Cannabis Sativa (QB)
EU
9478T
9478T
NYSE
NSAM
Colony NorthStar, Inc.
USOTC
RNSDF
Renault Sa Regie Nat (PK)
BIT
GLAE
Spdr Bbg Barclays Global...
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados